efficiently and cost-effectively. Read more about Triathlon. Vandalia is helping companies develop vaccines, diagnostics, bio-agriculture, and gene therapies for existing and emerging markets, and is well-positioned as a key supplier for the research, clinical, and commercialization stages of these products.

Vandalia Research was formed in March 2004 as a spinout from Marshall University in Huntington, WV. Vandalia has placed strong emphasis on research and development directed to specific market needs, with the primary objective of commercializing novel biotechnology instrumentation and advanced biotechnology manufacturing techniques.